Find information on thousands of medical conditions and prescription drugs.

Ceftazidime

Ceftazidime is an antibiotic which eliminates bacteria that cause many kinds of infections, including lung, skin, bone, joint, stomach, blood, gynecological, and urinary tract infections. This medication is sometimes prescribed for other uses. more...

Home

Caduet

Calan

Campath

Capoten

Cardura

Casodex

Cathine

Ceclor

Cefotan

Cefzil

Celexa

Cerebyx

Chenodeoxycholic acid

Cholac

Choriogonadotropin alfa

Chorionic gonadotropin

Cialis

Cipro

Climara

Clomid

Colyte

Commit

Coreg

Corgard

Cotrim

Cozaar

Crestor

Cylert

Cytotec

Ceftazidime has many commercial names depending on the country it is used. Go to Ceftazidime information on CBWInfo to learn more about those names and the antibiotic itself.

Ceftazidime is a third-generation cephalosporin, given intravenously or intramuscularly. Usual dose is 1-2 g IV or IM every 8 to 12 hours, though this can vary by the indication for the antibiotic, and for the renal function of the recipient. Ceftazidime has activity against gram-negative organisms including Pseudomonas and Enterobacteriaceae. Its activity against Pseudomonas is a distinguishing feature of ceftazidime among the cephalosporins. It is also used in the empiric therapy of febrile neutropenia.

Ceftazidime is a U.S. pregnancy category B pharamceutical agent, and is excreted in breast milk.

Read more at Wikipedia.org

• [List your site here Free!]


	Strategies for Pharmacokinetic Optimization of Continuous Infusion Therapy of Ceftazidime and Aztreonam in Patients with Cystic Fibrosis $76.86	Advantage to meropenem combo therapy for CF exacerbations: effect not sustained long term.(Women's Health)(cystic fibrosis) : An article from: Family Practice News $5.95


The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic Background: Cystic fibrosis (CF) is characterized by chronic pulmonary infection with acute pulmonary exacerbations (APEs) requiring IV antibiotic treatment. From CHEST, 10/1/05 by Jeffrey L. Blumer

Ceftazidime monotherapy for pulmonary melioidosis in a traveler returning from Thailand - Tropical Lung Disease The spread of tropical diseases increases with growing worldwide travel activity and the influx of refugees into the Western world. Unfamiliarity with ... From CHEST, 2/1/92 by Robert W. Sauerwein

Cefepime MIC as a predictor of the extended-spectrum [beta]-lactamase type in Klebsiella pneumoniae, Taiwan - Dispatches To guide selection of carbapenems or fourth-generation cephalosporins as therapy, 110 Klebsiella pneumoniae isolates with extended-spectrum [beta]-lactamases ... From Emerging Infectious Diseases, 5/1/02 by Wen Liang Yu

Clinical characteristics and outcome of severe melioidosis requiring intensive care Study objective: To describe the clinical characteristics and outcome of patients with severe melioidosis requiring intensive care. Design: Retrospective ... From CHEST, 11/1/05 by Kenneth P.W. Chan

Anterior lumbar interbody fusion—advances in spinal fusion technology AS MUCH AS 80% OF THE US POPULATION will be affected by back pain at some time during their lives. Some of the most common disorders are herniated disc, degenerative disc disease, degenerative spo From AORN Journal, 11/1/05 by Sharon Brady

Drug-resistant Escherichia coli, rural Idaho Stool carriage of drug-resistant Escherichia coli in home-living residents of a rural community was examined. Carriage of nalidixic acid-resistant E. From Emerging Infectious Diseases, 10/1/05 by Elizabeth L. Hannah

Phenotypic characteristics of clinical isolates of Klebsiella pneumoniae & evaluation of available phenotypic techniques for detection of extended Background & objectives: Identifying organisms that harbour extended spectrum beta lactamases (ESBLs) is a major challenge for a diagnostic clinical microbiology ... From Indian Journal of Medical Research, 10/1/05 by Manchanda, Vikas

Melioidosis in New Caledonia Recognized melioidosis-endemic areas are widening. In the South Pacific, melioidosis is endemic in New Caledonia, northern Australia, and Papua New Guinea, We report the first 4 documented cases of From Emerging Infectious Diseases, 10/1/05 by Simon Le Hello

Home

Contact

Resources

Exchange Links

ebay